论文信息 - Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naïve Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial: 487 - 字舞流文

Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naïve Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial: 487

T. Asselah | J. Dufour | S. Zeuzem | C. Sarrazin | M. Omata | J. Crespo | P. Ferenci | G. Foster | K. Agarwal | M. Bourlière | Christophe Moreno | M. Schuchmann | D. Forton | L. Morano | A. Quinson | J. Stern | M. Maevskaya | E. Zehnter | J. Scherer | F. Calinas | Y. Datsenko | S. Nishigushi